Abstract
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive mediastinal staging tool for lung cancer but also a diagnostic tool for mediastinal lesions near the airway. This review focuses primarily on the technique of linear probe EBUS-TBNA itself, training and financial issues, indications and performance, and pros and cons compared to other mediastinal sampling techniques. As such, it is relevant to centres considering to establish an EBUS-TBNA service. EBUS-TBNA is the most commonly used for staging non-small cell lung cancer (NSCLC), particularly bulky mediastinal lymphadenopathy and enlarged N2 or N3 disease on CT, but is also used for the diagnosis of unexplained mediastinal lymphadenopathy of other causes. For staging when radical treatment is contemplated, many centres still perform mediastinoscopy and this should be done in order to corroborate negative EBUS-TBNA results in this setting or when the pre-test clinical probability of lung cancer is high. EBUS-TBNA may be used in the future for staging, when the mediastinal nodes are normal according to radiological staging and also in re-staging. EBUS-TBNA can be learned with appropriate training and mentorship; it offers numerous advantages over mediastinoscopy and can reduce costs by avoiding mediastinoscopy (and the required peri-operative support) in many cases.
Keywords: Lung cancer, diagnosis, staging, endobronchial ultrasound, transbronchial needle aspiration, mediastinoscopy
Current Respiratory Medicine Reviews
Title: Applications of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) in Pulmonary Disease
Volume: 6 Issue: 2
Author(s): Andrew R.L. Medford
Affiliation:
Keywords: Lung cancer, diagnosis, staging, endobronchial ultrasound, transbronchial needle aspiration, mediastinoscopy
Abstract: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive mediastinal staging tool for lung cancer but also a diagnostic tool for mediastinal lesions near the airway. This review focuses primarily on the technique of linear probe EBUS-TBNA itself, training and financial issues, indications and performance, and pros and cons compared to other mediastinal sampling techniques. As such, it is relevant to centres considering to establish an EBUS-TBNA service. EBUS-TBNA is the most commonly used for staging non-small cell lung cancer (NSCLC), particularly bulky mediastinal lymphadenopathy and enlarged N2 or N3 disease on CT, but is also used for the diagnosis of unexplained mediastinal lymphadenopathy of other causes. For staging when radical treatment is contemplated, many centres still perform mediastinoscopy and this should be done in order to corroborate negative EBUS-TBNA results in this setting or when the pre-test clinical probability of lung cancer is high. EBUS-TBNA may be used in the future for staging, when the mediastinal nodes are normal according to radiological staging and also in re-staging. EBUS-TBNA can be learned with appropriate training and mentorship; it offers numerous advantages over mediastinoscopy and can reduce costs by avoiding mediastinoscopy (and the required peri-operative support) in many cases.
Export Options
About this article
Cite this article as:
R.L. Medford Andrew, Applications of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) in Pulmonary Disease, Current Respiratory Medicine Reviews 2010; 6 (2) . https://dx.doi.org/10.2174/157339810791171241
DOI https://dx.doi.org/10.2174/157339810791171241 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
<sup>99m</sup>Tc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases)
Current Radiopharmaceuticals Severe Hypoglycemia Due to Possible Interaction Between Glibenclamide and Sorafenib in a Patient with Hepatocellular Carcinoma
Current Drug Safety Heavy Metal Toxicity in Humans and its Preventive and Control Measures
Current Nutrition & Food Science Small Molecule Toxins Targeting Tumor Receptors
Current Pharmaceutical Design Matrix Metalloproteinases and Colon Anastomosis Repair: A New Indication for Pharmacological Inhibition?
Mini-Reviews in Medicinal Chemistry LncRNA HOTAIR as Prognostic Circulating Marker and Potential Therapeutic Target in Patients with Tumor Diseases
Current Drug Targets Genetic Variation at the Human MGMT Locus and its Biological Consequences
Current Pharmacogenomics The Changing Face of HDAC Inhibitor Depsipeptide
Current Cancer Drug Targets Peptides Targeting Angiogenesis Related Growth Factor Receptors
Current Pharmaceutical Design Difference Gel Electrophoresis: Application in Quantitative Proteomics Research
Current Proteomics Prediction of the Ebola Virus Infection Related Human Genes Using Protein-Protein Interaction Network
Combinatorial Chemistry & High Throughput Screening MicroRNA-203: Tumor Suppression and Beyond
MicroRNA The Role of the Osteoimmune Axis in the Inflammation of the Inner Auditory Ear and with Regard to the Putative Anticarcinogenetic Principle: Part 2
Inflammation & Allergy - Drug Targets (Discontinued) Blood Immunoglobulins, Complement and TNF Receptor Following Minimally Invasive Surgery in Patients Undergoing Pulmonary Lobectomy
Current Metabolomics H3K4 Methylation Status and Lysine Specific Methyltransferase KMT2C Expression Correlate with Prognosis in Lung Adenocarcinoma
Current Molecular Pharmacology The Role of XRCC4 in Carcinogenesis and Anticancer Drug Discovery
Recent Patents on Anti-Cancer Drug Discovery Cyclodextrin-based Polymeric Nanoparticles as Efficient Carriers for Anticancer Drugs
Current Pharmaceutical Biotechnology Potential Benefits of Glitazones for Cancer and Vascular Disease
Current Drug Therapy Subject Index to Volume 10
Protein & Peptide Letters Mechanism of Action of Limonene in Tumor Cells: A Systematic Review and Meta-Analysis
Current Pharmaceutical Design